BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31530281)

  • 21. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
    Wei C; Jing J; Zhang Y; Fang L
    Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D; Lu G; Shao Y; Xu D
    Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
    Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
    Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
    Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
    Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer analysis of the developmental pathways reveals non-canonical wnt signaling as a driver of mesenchymal-type tumors.
    Xue AG; Chan M; Gujral TS
    Transl Res; 2020 Oct; 224():1-15. PubMed ID: 32522670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src and Fyn define a new signaling cascade activated by canonical and non-canonical Wnt ligands and required for gene transcription and cell invasion.
    Villarroel A; Del Valle-Pérez B; Fuertes G; Curto J; Ontiveros N; Garcia de Herreros A; Duñach M
    Cell Mol Life Sci; 2020 Mar; 77(5):919-935. PubMed ID: 31312879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Numerical modelling of WNT/β-catenin signal pathway in characterization of EMT of colorectal carcinoma cell lines after treatment with Pt(IV) complexes.
    Šeklić DS; Đukić T; Milenković D; Jovanović MM; Živanović MN; Marković Z; Filipović N
    Comput Methods Programs Biomed; 2022 Nov; 226():107158. PubMed ID: 36198204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN suppresses epithelial-mesenchymal transition and cancer stem cell activity by downregulating Abi1.
    Qi Y; Liu J; Chao J; Scheuerman MP; Rahimi SA; Lee LY; Li S
    Sci Rep; 2020 Jul; 10(1):12685. PubMed ID: 32728066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.
    Zhiping C; Shijun T; Linhui W; Yapei W; Lianxi Q; Qiang D
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4835-4843. PubMed ID: 29164579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
    Gasior K; Hauck M; Wilson A; Bhattacharya S
    Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
    Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.